David Krempa | Vice President of Business Development |
Sean Brynjelsen | Chief Executive Officer |
Paul Stickler | Senior Vice President of Sales and Marketing |
Wilson Troutman | Chief Financial Officer |
Ram Selvaraju | H.C. Wainwright |
Andrew D’silva | B.Riley FBR |
Brooks O'Neil | Lake Street Capital |
Good afternoon, and welcome to Eton Pharmaceuticals Second Quarter 2020 Financial and Operating Results Conference Call. At this time, all participants are in a listen-only mode.
Following the formal remarks, we will open the call for your questions. Please be advised that this call is being recorded at the Company's request. At this time, I'd like to turn the call over to David Krempa, Vice President of Business Development at Eton Pharmaceuticals.